GlassScriptPhysician profile
Warren L Cooper
NPI 1740288687
$1,424.64
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $258 · 2021: $813.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $393.26 | 2021 | |
| Abbvie INC. | $238.86 | 2019-2021 | |
| Minerva Surgical, INC | $110.61 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.73 | 2019-2021 | |
| Boston Scientific Corporation | $90.00 | 2019-2020 | |
| Daiichi Sankyo INC. | $70.39 | 2019-2020 | |
| Myovant Sciences INC. | $64.95 | 2021 | |
| Pfizer INC. | $63.30 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $54.50 | 2020-2021 | |
| Baxter Healthcare | $32.90 | 2020-2021 | |
| Allergan, INC. | $32.49 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $31.64 | 2021 | |
| Organon LLC | $26.27 | 2021 | |
| Exeltis, USA INC. | $25.43 | 2020-2021 | |
| Meditrina | $25.02 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $23.34 | 2021 | |
| Astellas Pharma US INC | $13.99 | 2019 | |
| Hologic Sales and Service, LLC | $13.96 | 2019 | |
| Therapeuticsmd, INC. | $12.00 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.